Insider Stock Sales Shake Up ACELYRIN, INC.

TipRanksMar 19 22:06 ET

Insider Sale: Chief Executive Officer of $SLRN Sells 17,986 Shares

Quiver QuantitativeMar 19 18:16 ET

Acelyrin | 10-K: FY2024 Annual Report

SECMar 19 16:05 ET · Announcements

Acelyrin Adopts Poison Pill as Tang Capital Partners Builds Stake

WSJMar 13 08:15 ET

Acelyrin Adopts Stockholder Rights Plan; Shares Up Pre-Bell

MT NewswiresMar 13 08:08 ET

Express News | ACELYRIN Adopts Limited-Duration Stockholder Rights Plan

ReutersMar 13 07:00 ET

Express News | ACELYRIN Shares Down 6.5% After Co Reiterates Merger With Alumis

ReutersMar 4 11:14 ET

Express News | Refile-Buzz-ACELYRIN Slides After Reiterating Merger With Alumis Amid Concentra's Buyout Offer

ReutersMar 4 10:31 ET

Acelyrin Falls as Acelyrin Reaffirms Deal Commitment

Seeking AlphaMar 4 09:37 ET

Acelyrin Says Concentra Indication Not Expected to Result in Superior Proposal

TipRanksMar 4 09:12 ET

Acelyrin and Alumis: Combined Company to Benefit From Differentiated Late-Stage Portfolio of Therapies and Strong Balance Sheet

Dow JonesMar 4 09:03 ET

ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger

GlobeNewswireMar 4 09:01 ET

Press Release: ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger

Dow JonesMar 4 09:01 ET

Press Release: Alumis and ACELYRIN Reaffirm Strategic and Financial Rationale of Proposed Merger

Dow JonesMar 4 09:01 ET

Top-rated Biotechs With Negative Enterprise Values

Seeking AlphaMar 1 14:28 ET

Key Deals This Week: Howard Hughes, Shift4 Payments, Herc Holdings, Celsius and More

Seeking AlphaFeb 22 15:35 ET

Acelyrin (SLRN) Stock Surges After Unsolicited Buyout Proposal

Stocks TelegraphFeb 21 11:04 ET

Acelyrin Stock Jumps on Concentra Acquisition Interest

WSJFeb 21 09:16 ET

Reported Earlier, ACELYRIN Confirms Unsolicited $3/Share Offer From Concentra Biosciences Amid Pending Alumis Merger

BenzingaFeb 21 01:18 ET

Express News | ACELYRIN Confirms Receipt of Unsolicited Indication of Interest From Concentra Biosciences

ReutersFeb 20 21:01 ET